Oxidative stress and neural dysfunction in Down syndrome.
Total or partial trisomy of chromosome 21 occurs with relatively high frequency and is responsible for the occurrence of Down syndrome. Phenotypically, individuals with Down syndrome display characteristic morphological features and a variety of clinical disorders. One of the challenges for researchers in this field has been to ascertain and understand the relationship between the Down syndrome phenotype with the gene dosage effect resulting from trisomy of chromosome 21. Much attention therefore, has been given towards investigating the consequences of overexpressing chromosome 21-linked genes. In particular, an extensive analysis of SOD1 and APP have provided important insights as to how perturbations in the expression of their respective genes may contribute to the Down syndrome phenotype. In this review we will highlight studies which support a key role for SOD1 and APP in the pathogenesis of neural abnormalities observed in individuals with Down syndrome. Central to this relationship is how the redox state of the cell is affected and its consequences to neural function and integrity.
Iannello
R C
RC
Centre for Functional Genomics and Human Disease, Monash Medical Centre, Clayton, Australia.
Crack
P J
PJ
de Haan
J B
JB
Kola
I
I
D000544:Alzheimer Disease / Q000235:genetics / Q000503:physiopathology; D016564:Amyloid beta-Protein Precursor / Q000235:genetics; D004314:Down Syndrome / Q000235:genetics / Q000503:physiopathology*; D018628:Gene Dosage; D006801:Humans; D009474:Neurons / Q000502:physiology*; D018384:Oxidative Stress; D013482:Superoxide Dismutase / Q000235:genetics
D016564:Amyloid beta-Protein Precursor; D013482:Superoxide Dismutase